Latest News

Diabetes drug shows promise in reducing Alzheimer's disease in an experimental model

The diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease in the brain and improves learning and memory in two experimental Alzheimer's disease models, researchers have discovered. These results also found Alzheimer's disease patients have a lower level of amylin in blood compared to those without this disease, and may provide a new avenue for both treatment and diagnosis of Alzheimer's disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • No cookie-cutter divorces, so what info should online co-parenting classes offer?

  • Healthy working environment is a salvation

  • Warm thanks: Gratitude can win you new friends

  • Learning to read: Tricking the brain

  • Meaningful relationships can help you thrive

  • Memory in silent neurons: How do unconnected neurons communicate?

  • Brain networks 'hyper-connected' in young adults who had depression

  • New treatment for Multiple Sclerosis being investigated

  • How does it feel to be old in different societies?

  • Bedsharing with baby may impair sleep quality

  •